Chemical screen identifies PRMT5 as therapeutic target for paclitaxel-resistant triple-negative breast cancer
In a study published in Cell Chemical Biology, a research team led by Prof. Tan Weihong and Prof. Wu Qin from the Hangzhou Institute of Medical of the Chinese Academy of Sciences has identified protein …